Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Two rare genetic diseases cause severe rickets in children due to defects in vitamin D metabolism.

Chronic stress in mice changes skin metabolism and gene expression, leading to hair loss.

Stabilizing HIF-1A in hair follicles may reduce oxidative stress and promote hair growth by increasing glycolysis.

Certain genes are more active during wound healing in axolotl and Acomys, which could help develop materials that improve human wound healing and regeneration.

Different hair follicles in the skin are innervated by unique combinations of mechanosensory neurons, crucial for touch sensation.

Genetic variants can affect valproic acid's effectiveness, side effects, and levels in epilepsy treatment.

Inositol and phytic acid together increase hair growth and density.

Spironolactone can cause side effects like irregular bleeding, but lower doses may reduce these effects and still improve hirsutism.

Cosmeceuticals may benefit skin health but need more research for efficacy and safety confirmation.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Hairless protein can block vitamin D activation in skin cells.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

The new scalp treatment preserves hair color, reduces hair loss, and maintains hair strength.

The document concludes that effective acne treatment requires a personalized combination of therapies and long-term commitment, with retinoids being important for maintenance.

A young man with an eating disorder had a life-threatening adrenal crisis due to an autoimmune condition, highlighting the need for better education on managing hormone treatments.

A genetic marker linked to a type of hair loss was found in most patients studied.

Researchers developed a method to identify and analyze cyclosporin compounds and their structures effectively.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.